Presence of complex t(6;9;22;15) four-way chromosome rearrangement plus rare t(1;6) translocation with favorable response to imatinib therapy in chronic myelogenous leukemia

Leuk Lymphoma. 2011 Nov;52(11):2182-4. doi: 10.3109/10428194.2011.585674. Epub 2011 Jun 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Chromosomes, Human, Pair 1
  • Chromosomes, Human, Pair 15
  • Chromosomes, Human, Pair 22
  • Chromosomes, Human, Pair 6
  • Chromosomes, Human, Pair 9
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Translocation, Genetic*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate